HHS Price-Setting Regs Could Be Authorized Under Democratic Medicare Plan
House Democrats are considering whether legislation to create a PBM-administered Medicare prescription drug benefit should allow HHS to issue rules ensuring that the Medicare program receives drugs at the same prices as other large group purchasers.
You may also be interested in...
A proposed Medicare board "may not be the best choice of organizational structure" to oversee a new Medicare premium-support program, Medicare Payment Advisory Commission Chairman Gail Wilensky told a Senate Finance Committee hearing May 4.
Pharmacy benefit management contracts to administer a Medicare prescription drug benefit would run for five years under a proposal being considered by the House Democratic leadership for introduction the week of May 8.
Private-insurance based Medicare proposals do not offer enough leverage on price, Rep. Allen (D-Maine) told a May 3 briefing on health care sponsored by the Council for Affordable Health Insurance in Washington, D.C.